United Health Products, Inc. (UEEC) stock
UEECOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 0/30
$0.04−0.01 (-23.53%)
Close on Oct 19, 2026Market cap $10.25MP/E –Yield –
United Health Products operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
United Health Products's operating cash flow for the twelve months ending Sep 30, 2026 was -$969.75K. For fiscal 2025 it was -$1.19M. The highest annual figure on record is -$2.18K in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.19M | – |
| FY2024 | Dec 31, 2024 | -$1.19M | – |
| FY2023 | Dec 31, 2023 | -$2.20M | – |
| FY2022 | Dec 31, 2022 | -$619.72K | – |
| FY2021 | Dec 31, 2021 | -$828.08K | – |
| FY2020 | Dec 31, 2020 | -$1.33M | – |
| FY2019 | Dec 31, 2019 | -$1.77M | – |
| FY2018 | Dec 31, 2018 | -$1.28M | – |
| FY2017 | Dec 31, 2017 | -$649.68K | – |
| FY2016 | Dec 31, 2016 | -$473.35K | – |
| FY2015 | Dec 31, 2015 | -$844.04K | – |
| FY2014 | Dec 31, 2014 | -$334.83K | – |
| FY2013 | Dec 31, 2013 | -$118.80K | – |
| FY2012 | Dec 31, 2012 | -$2.18K | – |
| FY2011 | Dec 31, 2011 | -$284.32K | – |
| FY2010 | Dec 31, 2010 | -$691.94K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$194.28K | – |
| Q2 FY2026 | Jun 30, 2026 | -$138.01K | – |
| Q1 FY2026 | Mar 31, 2026 | -$84.34K | – |
| Q4 FY2025 | Dec 31, 2025 | -$553.13K | – |
| Q3 FY2025 | Sep 30, 2025 | -$175.16K | – |
| Q2 FY2025 | Jun 30, 2025 | -$184.69K | – |
| Q1 FY2025 | Mar 31, 2025 | -$273.97K | – |
| Q4 FY2024 | Dec 31, 2024 | -$181.44K | – |
| Q3 FY2024 | Sep 30, 2024 | -$319.80K | – |
| Q2 FY2024 | Jun 30, 2024 | -$287.72K | – |
| Q1 FY2024 | Mar 31, 2024 | -$405.76K | – |
| Q4 FY2023 | Dec 31, 2023 | -$576.50K | – |
| Q3 FY2023 | Sep 30, 2023 | -$604.78K | – |
| Q2 FY2023 | Jun 30, 2023 | -$471.23K | – |
| Q1 FY2023 | Mar 31, 2023 | -$548.14K | – |
| Q4 FY2022 | Dec 31, 2022 | -$218.44K | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.10K | – |
| Q2 FY2022 | Jun 30, 2022 | -$203.47K | – |
| Q1 FY2022 | Mar 31, 2022 | -$195.72K | – |
| Q4 FY2021 | Dec 31, 2021 | -$370.45K | – |
| Q3 FY2021 | Sep 30, 2021 | -$194.09K | – |
| Q2 FY2021 | Jun 30, 2021 | -$153.06K | – |
| Q1 FY2021 | Mar 31, 2021 | -$110.49K | – |
| Q4 FY2020 | Dec 31, 2020 | -$145.37K | – |
| Q3 FY2020 | Sep 30, 2020 | -$276.15K | – |
| Q2 FY2020 | Jun 30, 2020 | -$400.86K | – |
| Q1 FY2020 | Mar 31, 2020 | -$503.48K | – |
| Q4 FY2019 | Dec 31, 2019 | -$520.96K | – |
| Q3 FY2019 | Sep 30, 2019 | -$412.68K | – |
| Q2 FY2019 | Jun 30, 2019 | -$612.17K | – |
| Q1 FY2019 | Mar 31, 2019 | -$220.96K | – |
| Q4 FY2018 | Dec 31, 2018 | -$377.91K | – |
| Q3 FY2018 | Sep 30, 2018 | -$273.37K | – |
| Q2 FY2018 | Jun 30, 2018 | -$309.01K | – |
| Q1 FY2018 | Mar 31, 2018 | -$318.38K | – |
| Q4 FY2017 | Dec 31, 2017 | -$354.13K | – |
| Q3 FY2017 | Sep 30, 2017 | -$150.16K | – |
| Q2 FY2017 | Jun 30, 2017 | -$52.24K | – |
| Q1 FY2017 | Mar 31, 2017 | -$93.15K | – |
| Q4 FY2016 | Dec 31, 2016 | -$160.51K | – |
See a number that looks wrong?